Sasaki et al. addressed the toxicity of IL-12 that has caused dose-limiting immune-related adverse events (irAEs). https://t.co/rrRrxXwiQD @Ko1Sasaki@BioengIshihara
Congratulations to Prof. David Baker on his Nobel Prize. @ImperialBioeng@imperialcollege hosted him for a seminar a few years ago! https://t.co/4Jv0G9QTMv
Merry Christmas from the Ishihara lab. Our lab is still two years-old, but grew rapidly. We celebrated our achievements, diversity and team working culture.
https://t.co/l2brssLx9U
Japanese research is no longer world class here’s why.
A lot of young Japanese researchers went outside of Japan for better research environment
I became a researcher because I wanted to solve unmet needs. I truly believe that with this funding, we can make a difference in brain tumors therapies.
We’ve awarded £1.5 million grant to find new ways to treat #glioblastoma at @imperialcollege. Led by Dr Jun Ishihara @BioengIshihara, researchers will harness the power of the immune system to help fight recurrent glioblastoma cells. https://t.co/EsYmwVxfwG
Excited to share that I have accepted a position as Assistant Professor at @UChicago and that my lab will open its doors in October 2023 as part of @UChicagoImmuno. Contact me if you are interested in studying mechanisms of peripheral tolerance with us!
I am thrilled to share this news. Our lab was funded by the Brain tumour charity, with 1.5 million GBP, 5 years. Our ambition is to create drug for the patients who desperately need therapeutic options.
@BrainTumourCSO@imperialcollege@ImperialBioeng https://t.co/4Gka8V5Fd1
So excited for our new publication in @NatureComms demonstrating a novel membrane-bound IL-12 engineered regionally-delivered CAR T cell approach to target multi-metastatic solid tumors. Congrats to @heejunlee920505, @JohnPMuradPhD and #pricemanlab#coh https://t.co/fqubwS2qiK
Thrilled to have hosted the Korean Minister of Health & Welfare at our institute last week. Minister Cho met with some of the minds behind SKYCovione, our pioneering COVID-19 vaccine developed with SK bioscience. Proud to showcase our groundbreaking work in protein design.
My lab at Imperial college London is still hiring two postdocs! Share this post to someone who is interested in immuno-engineering and immuno-oncology.https://t.co/KZF7YurZEq
#postdoc#postdocposition#imperialcollegelondon
I am so proud of Jeff. I have been working with him for 9 years. He is a great researcher, mentor and respectful person. Joining his lab was my best decision in my life.
@UChicagoPME professor Jeffrey Hubbell has been elected into the @theNASciences for his work in bioengineering and immunotherapy. 👏
Hubbell is the only current @UChicago faculty member to be elected to all three academies - Sciences, Engineering, and Medicine.